NASDAQ: VCNX       Vaccinex Inc
Last Price Today's Change   Day's Range   Trading Volume
1.78   -0.02 (1.11%)  1.73 - 1.872  96,314


Avg Volume (4 weeks):999,375
4 Weeks Range:1.65 - 2.29
4 Weeks Price Volatility (%):
52 Weeks Range:1.63 - 12.23
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Vaccinex Inc is a clinical-stage biotechnology company. It is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The company’s lead platform technologies include SEMA4D antibody platform and ActivMAb antibody discovery platform. Its lead product candidate VX15 is in clinical development for the treatment of NSCLC, osteosarcoma and Huntington’s disease and additional product candidates VX5 and VX25 are in earlier stages of development.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3064  2715  468  3155 

Top 10 Active Counters
 LK 1.38+1.38 
 OAS 0.155-0.014 
 NIO 29.837+2.327 
 NOK 3.305-0.745 
 PINS 66.50+17.25 
 GE 7.56+0.14 
 F 8.095+0.395 
 AMTD 39.97-0.85 
 PGNX 4.10-0.425 
 XOG 0.271-0.062